Psyence Biomedical

Psyence Biomedical EBIT per Share

The EBIT per Share of Psyence Biomedical (PBM) as of Oct 13, 2026 is -11.29 USD. In the previous year, EBIT per Share was -2.47 USD — a change of 356.77% (lower).

EBIT per Share

-11.29USD

YoY

356.77%

Last updated:

EBIT per Share of Psyence Biomedical is 2026 -11.29 USD. EBIT per Share of Psyence Biomedical was 2025 -2.47 USD. It decreases by 356.77% lower compared to the previous year.

The Psyence Biomedical EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
-0.01 USD
Jan 1, 2022
-0.01 USD
Jan 1, 2023
-0.23 USD
Jan 1, 2024
-184.70 USD
Jan 1, 2025
-2.47 USD
Jan 1, 2026
-11.29 USD
The Psyence Biomedical EBIT per Share history
YEAREBIT per ShareYoY
-11.29USD+356.77%
-2.47USD-98.66%
-184.70USD+80,441.54%
-0.23USD+3,093.69%
-0.01USD-28.89%
-0.01USD—
Access this data via the Eulerpool API
Get Free API Key

Psyence Biomedical Stock analysis

What does Psyence Biomedical do? Psyence Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psyence Biomedical stock

EBIT per Share of Psyence Biomedical is -11.29 USD in 2026.

EBIT per Share of Psyence Biomedical changed from -2.47 USD to -11.29 USD, representing a 356.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Psyence Biomedical since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Psyence Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Psyence Biomedical